Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Clene Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +7 vs. Q3 2024
- Shares held
- 491.4K
- −524.1K (−51.6%) vs. Q3 2024
- Total value
- $2.60M
- −$2.06M (−44.2%) vs. Q3 2024
- New holders
- 10
- 4 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $5 | 0.00% | +1 | New |
| UBS Group AG | 9 | $48 | 0.00% | +1+12.5% | Added |
| BNP Paribas Arbitrage, SA | 13 | $69 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 20 | $106 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $244 | 0.00% | −68−59.6% | Reduced |
| Wells Fargo & Company | 50 | $266 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 100 | $531 | 0.00% | +100 | New |
| Washington Trust Co | 150 | $797 | 0.00% | +150 | New |
| Tower Research Capital LLC (TRC) | 672 | $3.57K | 0.00% | −281−29.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,045 | $5.55K | 0.00% | −562−35.0% | Reduced |
| SRS Capital Advisors, Inc. | 2,112 | $11.2K | 0.00% | −500−19.1% | Reduced |
| Atlantic Private Wealth, LLC | 2,205 | $11.7K | 0.01% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,333 | $12.4K | 0.00% | +2,333 | New |
| BlackRock, Inc. | 4,171 | $22.1K | 0.00% | 00.0% | Unchanged |
| Fullcircle Wealth LLC | 13,023 | $59.4K | 0.02% | +13,023 | New |
| Northern Trust Corp | 11,497 | $61.0K | 0.00% | 00.0% | Unchanged |
| Castleview Partners, LLC | 11,547 | $62.2K | 0.03% | −1,236−9.7% | Reduced |
| State Street Corp | 12,501 | $66.4K | 0.00% | +12,501 | New |
| SBI Securities Co., Ltd. | 13,025 | $69.2K | 0.00% | +13,025 | New |
| Morgan Stanley | 16,931 | $89.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 18,040 | $95.8K | 0.00% | +18,040 | New |
| Citadel Advisors LLC | 20,835 | $110.6K | 0.00% | +20,835 | New |
| Lunt Capital Management, Inc. | 29,793 | $158.2K | 0.06% | +253+0.9% | Added |
| Parsons Capital Management Inc | 36,500 | $193.8K | 0.01% | +36,500 | New |
| Geode Capital Management, LLC | 65,112 | $345.8K | 0.00% | +22,539+52.9% | Added |
| Scoggin Management LP | 100,000 | $531.0K | 0.28% | +25,000+33.3% | Added |
| Vanguard Group Inc | 129,620 | $688.3K | 0.00% | −1,486−1.1% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −682,374−100.0% | Sold out |
| Partnership Wealth Management, LLC | 0 | $0 | 0.00% | −1,875−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |